Buono Stefano
Insider CIK 1665113 · NWCL Chief Executive Officer, Director · ABEO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NWCL newcleo plc | A Award deriv | 2026-09-21 | 2026-09-23 | 134,596 | — | $0 | 134,596 | SEC↗ |
| NWCL newcleo plc | A Award deriv | 2026-09-21 | 2026-09-23 | 4,291 | — | $0 | 4,291 | SEC↗ |
| NWCL newcleo plc | A Award deriv | 2026-09-21 | 2026-09-23 | 9,814 | — | $0 | 9,814 | SEC↗ |
| NWCL newcleo plc | A Award deriv | 2026-09-21 | 2026-09-23 | 11,960 | — | $0 | 11,960 | SEC↗ |
| NWCL newcleo plc | A Award deriv | 2026-09-21 | 2026-09-23 | 1,921,029 | — | $0 | 1,921,029 | SEC↗ |
| NWCL newcleo plc | A Award deriv | 2026-09-21 | 2026-09-23 | 1,921,029 | — | $0 | 1,921,029 | SEC↗ |
| NWCL newcleo plc | A Award deriv | 2026-09-21 | 2026-09-23 | 11,960 | — | $0 | 11,960 | SEC↗ |
| NWCL newcleo plc | A Award deriv | 2026-09-21 | 2026-09-23 | 9,814 | — | $0 | 9,814 | SEC↗ |
| NWCL newcleo plc | A Award deriv | 2026-09-21 | 2026-09-23 | 4,291 | — | $0 | 4,291 | SEC↗ |
| NWCL newcleo plc | A Award deriv | 2026-09-21 | 2026-09-23 | 134,596 | — | $0 | 134,596 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award deriv | 2020-05-20 | 2020-05-22 | 21,518 | — | $0 | 21,518 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award | 2020-05-20 | 2020-05-22 | 17,969 | — | $0 | 287,969 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | P Buy | 2019-12-24 | 2019-12-31 | 200,000 | $2.50 | $500.0K | 270,000 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award deriv | 2019-05-21 | 2019-05-23 | 19,827 | — | $0 | 19,827 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | P Buy | 2019-04-11 | 2019-04-12 | 49,020 | $7.91 | $387.7K | 70,000 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | P Buy | 2019-04-10 | 2019-04-12 | 20,980 | $7.54 | $158.2K | 20,980 | SEC↗ |
| ABEO ABEONA THERAPEUTICS INC. | A Award deriv | 2018-05-22 | 2018-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |